| Name | Title | Contact Details |
|---|
Harvard Pilgrim Health Care is a full-service health benefits company serving more than one million members throughout Massachusetts, New Hampshire, Maine, Connecticut, and beyond. We`re dedicated to improving the quality and value of health care for the people and communities we serve. We recognize that health care is not one size fits all, and we`re working every day to create value for our members by respecting their unique values, languages, and cultures. For more than 40 years, we have built a reputation for exceptional clinical quality, preventive care, disease management, and member satisfaction, and have consistently been rated among the top plans in the country. In 2013 Harvard Pilgrim Health Care was ranked #1 private health plan in America for the 10th consecutive year. (#1 plan information available at http://countusin.harvardpilgrim.org/privacy) An independent, not-for-profit organization known for innovation that delivers better health and cost management, Harvard Pilgrim offers a wide variety of health insurance options for companies, families, and individuals. Our fully-insured and self-insured PPO, POS, and HMO plans are available with multiple variations tailored to the needs of our members and their employers. So, wherever, whenever you are looking for a partner in health benefits, or a great place to work, count us in. Harvard Pilgrim Health Care includes Harvard Pilgrim Health Care, Harvard Pilgrim Health Care of New England, and HPHC Insurance Company.
Dfh is a Hiawatha, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PanVera is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Priority Life Care, a family-owned company, was built on the thought that every senior deserves quality care regardless of their economic background. With over a decade of experience, the family has been a pioneer in the industry giving a win-win solution for both seniors and coworkers (the #PLCfamily). Our focus on senior living includes independent living, assisted living, and memory care. The key to our approach is in our purpose of supporting independence. In addition to care, our residents are able to continue living out their lives with healthy choices tailored to their individual needs.